A Randomized Trial of Clopidogrel vs Ticagrelor After Off-Pump Coronary Bypass

被引:4
作者
Kim, Hyo-Hyun [1 ]
Yoo, Kyung-Jong [1 ]
Youn, Young -Nam [1 ,2 ]
机构
[1] Yonsei Univ, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiovasc Surg,Coll Med, Seoul, South Korea
[2] Yonsei Univ, Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiovasc Surg,Coll Med, 250 Seongsanno, Seoul 120752, South Korea
关键词
DUAL ANTIPLATELET THERAPY; PLATELET REACTIVITY; GRAFT PATENCY; ASPIRIN; EPTIFIBATIDE; METAANALYSIS; BIVALIRUDIN; EVENTS; SINGLE; ARREST;
D O I
10.1016/j.athoracsur.2022.10.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND This study aimed to compare the outcomes of aspirin in combination with either ticagrelor or clopi-dogrel after off-pump coronary artery bypass (OPCAB) in patients with clopidogrel resistance. METHODS Between November 2014 and November 2020, 1739 patients underwent OPCAB. Aspirin and clopidogrel treatment was initiated the day after surgery. On postoperative days 7 to 9, clopidogrel resistance was evaluated using a point-of-care assay. A total of 278 (18.9%) patients had clopidogrel resistance ( platelet reaction unit >208) and were enrolled in the study. The study investigators excluded patients with coresistance to aspirin (n = 74) and divided the remaining patients (mean age, 67.4 +/- 8.5 years) into 2 groups (an aspirin and ticagrelor group [AT group; n = 102] and an aspirin and clopidogrel group [AC group; n = 102]), randomly assigned using a 1:1 ratio block table. The primary end point was graft patency and major adverse cardiovascular events (MACEs; defined as the composite of cardiovascular mortality, myocardial infarction, and repeat revascularization at 1 year after OPCAB), and the coprimary end point was the graft patency rate. The data were analyzed using the intent-to-treat method. RESULTS The graft occlusion rates in the AT and AC groups were 3.9% and 5.9%, respectively (P = .52). Neither death from cardiovascular causes (1.0% vs 2.9%; P = .32) nor myocardial infarction showed significant differences (1.0% vs 3.9%; P = .18). No significant difference in the rates of major bleeding were found between the 2 groups (P = .75). However, the AT group was associated with a lower rate of MACEs after OPCAB (hazard ratio, 0.77; 95% CI, 0.684-0.891; P = .01). CONCLUSIONS These results suggest that ticagrelor may be associated with reducing MACEs in patients with clo-pidogrel resistance after OPCAB.
引用
收藏
页码:1127 / 1134
页数:8
相关论文
共 25 条
[1]   64-multislice detector computed tomography coronary angiography as potential alternative to conventional coronary angiography: a systematic review and meta-analysis [J].
Abdulla, Jawdat ;
Abildstrom, Steen Z. ;
Gotzsche, Ole ;
Christensen, Erik ;
Kober, Lars ;
Torp-Pedersen, Christian .
EUROPEAN HEART JOURNAL, 2007, 28 (24) :3042-3050
[2]   Inflammatory response after coronary revascularization with or without cardiopulmonary bypass [J].
Ascione, R ;
Lloyd, CT ;
Underwood, MJ ;
Lotto, AA ;
Pitsis, AA ;
Angelini, GD .
ANNALS OF THORACIC SURGERY, 2000, 69 (04) :1198-1204
[3]   High on-treatment platelet reactivity to both aspirin and clopidogrel is associated with the highest risk of adverse events following percutaneous coronary intervention [J].
Breet, Nicoline J. ;
van Werkum, Jochem W. ;
Bouman, Heleen J. ;
Kelder, Johannes C. ;
Harmsze, Ankie M. ;
Hackeng, Christian M. ;
ten Berg, Jurrien M. .
HEART, 2011, 97 (12) :983-990
[4]   Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis [J].
Buonamici, Piergiovanni ;
Marcucci, Rossella ;
Migliorini, Angela ;
Gensini, Gian Franco ;
Santini, Alberto ;
Paruccia, Rita ;
Moschi, Guia ;
Gori, Anna Maria ;
Abbate, Rosanna ;
Antoniucci, David .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (24) :2312-2317
[5]   Thrombotic complications in beating heart operations [J].
Cartier, R ;
Robitaille, D .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2001, 121 (05) :920-922
[6]   A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An Investigator-Initiated trial [J].
de Waha, Antoinette ;
Sandner, Sigrid ;
von Scheidt, Moritz ;
Boening, Andreas ;
Koch-Buettner, Katharina ;
Hammel, Dieter ;
Hambrecht, Rainer ;
Danner, Bernhard C. ;
Schoendube, Friedrich A. ;
Goerlach, Gerold ;
Fischlein, Theodor ;
Schmoeckel, Michael ;
Oberhoffer, Martin ;
Schulz, Rainer ;
Walther, Thomas ;
Ziegelhoeffer, Tibor ;
Knosalla, Christoph ;
Schoenrath, Felix ;
Beyersdorf, Friedheim ;
Siepe, Matthias ;
Attmann, Tim ;
Misfeld, Martin ;
Mohr, Friedrich-Wilhelm ;
Sievers, Hans-Hinrich ;
Joost, Alexander ;
Putman, Leon M. ;
Laufer, Guenther ;
Hamm, Christian ;
Zeymer, Uwe ;
Kastrati, Adnan ;
Radke, Peter W. ;
Lange, Ruediger ;
Cremer, Jochen ;
Schunkert, Heribert .
AMERICAN HEART JOURNAL, 2016, 179 :69-76
[7]   Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting: Does Off/On-Pump Play a Role? [J].
Deo, Salil V. ;
Dunlay, Shannon M. ;
Park, Soon J. .
AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (06) :1085-1085
[8]   Adverse impact of bleeding on prognosis in patients with acute coronary syndromes [J].
Eikelboom, John W. ;
Mehta, Shamir R. ;
Anand, Sonia S. ;
Xie, Changchun ;
Fox, Keith A. A. ;
Yusuf, Salim .
CIRCULATION, 2006, 114 (08) :774-782
[9]   Responsiveness to P2Y12 receptor inhibitors [J].
Esposito, Giovanni .
CURRENT OPINION IN CARDIOLOGY, 2011, 26 :S31-S37
[10]   Aspirin Plus Clopidogrel Therapy Increases Early Venous Graft Patency After Coronary Artery Bypass Surgery A Single-Center, Randomized, Controlled Trial [J].
Gao, Ge ;
Zheng, Zhe ;
Pi, Yi ;
Lu, Bin ;
Lu, Jinguo ;
Hu, Shengshou .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (20) :1639-1643